These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9876905)

  • 1. Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging.
    Wolansky LJ; Finden SG; Chang R; Conigliari M; Lee HJ; Shaderowsky PD; Cook SD
    Clin Imaging; 1998; 22(6):385-92. PubMed ID: 9876905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-dose versus single-dose gadoteridol in multiple sclerosis patients.
    Wolansky LJ; Bardini JA; Cook SD; Zimmer AE; Sheffet A; Lee HJ
    J Neuroimaging; 1994 Jul; 4(3):141-5. PubMed ID: 8061382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis.
    Yuh WT; Tali ET; Nguyen HD; Simonson TM; Mayr NA; Fisher DJ
    AJNR Am J Neuroradiol; 1995 Feb; 16(2):373-80. PubMed ID: 7726087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cerebral diseases: how much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T.
    Brekenfeld C; Foert E; Hundt W; Kenn W; Lodeann KP; Gehl HB
    Invest Radiol; 2001 May; 36(5):266-75. PubMed ID: 11323514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
    van Waesberghe JH; Castelijns JA; Roser W; Silver N; Yousry T; Lycklama à Nijeholt GJ; Adèr HJ; Uitdehaag BM; Radue EW; Polman CH; Kappos L; Miller DH; Barkhof F
    AJNR Am J Neuroradiol; 1997 Aug; 18(7):1279-85. PubMed ID: 9282855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast.
    Petersein J; Saini S; Mitchell DG; Davis PL; Johnson CD; Kuhlman JE; Parisky YR; Runge VM; Weinreb J; Bernardino ME
    AJR Am J Roentgenol; 1995 Nov; 165(5):1157-61. PubMed ID: 7572495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model.
    Runge VM
    Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
    Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
    Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases.
    Yuh WT; Fisher DJ; Runge VM; Atlas SW; Harms SE; Maravilla KR; Mayr NA; Mollman JE; Price AC
    AJNR Am J Neuroradiol; 1994 Jun; 15(6):1037-51. PubMed ID: 8073972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.
    Filippi M; Capra R; Campi A; Colombo B; Prandini F; Marcianò N; Gasparotti R; Comi G
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):526-30. PubMed ID: 8778257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
    Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
    Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
    Kremer S; Lamy J; Magnus A; Oesterle H; Jeantroux J; Trunet S; Armspach JP; Dietemann JL; de Sèze J
    Neurology; 2013 Jul; 81(3):206-10. PubMed ID: 23761623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
    Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M
    J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
    Filippi M; Yousry T; Campi A; Kandziora C; Colombo B; Voltz R; Martinelli V; Spuler S; Bressi S; Scotti G; Comi G
    Neurology; 1996 Feb; 46(2):379-84. PubMed ID: 8614498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.